“THE RISK OF THERAPY-RELATED MYELODYSPLASIA/ACUTE MYELOID LEUKEMIA IN HODGKIN LYMPHOMA HAS SUBSTANTIALLY DECREASED IN THE ABVD ERA ABOLISHING MECHLORETHAMINE AND PROCARBAZINE AND LIMITING VOLUMES AND DOSES OF RADIOTHERAPY”, Mediterr J Hematol Infect Dis, vol. 4, no. 1, p. e2012022, Apr. 2012, doi: 10.4084/mjhid.2012.022.